Last reviewed · How we verify
Anti-inflammatory drugs — Competitive Intelligence Brief
phase 3
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Anti-inflammatory drugs (Anti-inflammatory drugs) — Genentech, Inc.. Anti-inflammatory drugs reduce inflammation by inhibiting inflammatory pathways and mediators in the body.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Anti-inflammatory drugs TARGET | Anti-inflammatory drugs | Genentech, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Anti-inflammatory drugs CI watch — RSS
- Anti-inflammatory drugs CI watch — Atom
- Anti-inflammatory drugs CI watch — JSON
- Anti-inflammatory drugs alone — RSS
Cite this brief
Drug Landscape (2026). Anti-inflammatory drugs — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-inflammatory-drugs. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab